Research Article

Prevalence of Osteoporosis and Its Risk Factors in Men with COPD in Qazvin

Table 1

Frequency of different risk factors of osteoporosis in COPD patients.

VariableSpine valueFemur value
NormalOsteopeniaOsteoporosisNormalOsteopeniaOsteoporosis

Age (year)
 60–6910 (11.2%)19 (21.3%)26 (29.2%)0.4913 (14.6%)28 (31.5%)14 (15.7%)0.52
 70–798 (9%)8 (9%)11 (12.4%)7 (7.9%)9 (10.1%)11 (12.4%)
 80–890 (0%)3 (3.4%)4 (4.5%)1 (1.1%)3 (3.4%)3 (3.4%)
Smoking (pack/year)
 <202 (2.2%)8 (9%)8 (9%)0.765 (5.6%)9 (10.1%)4 (4.5%)0.82
 21–407 (7.9%)10 (11.2%)16 (18%)7 (7.9%)16 (18%)10 (11.2%)
 >409 (10.1%)12 (13.5%)17 (19.1%)9 (10.1%)15 (16.9%)14 (15.7%)
Severity of COPD
 Mild (grade I)6 (6.7%)4 (4.5%)7 (7.9%)0.385 (5.6%)9 (10.1%)3 (3.4%)0.042
 Moderate (grade II)1 (1.1%)6 (6.7%)7 (7.9%)6 (6.7%)3 (3.4%)5 (5.6%)
 Severe (grade III)3 (3.4%)11 (12.4%)13 (14.6%)3 (3.4%)17 (19.1%)7 (7.9%)
 Very severe (grade IV)8 (9%)9 (10.1%)14 (15.7%)7 (7.9%)11 (12.4%)13 (14.6%)
BMI
 Low 19 (21.3%)13 (14.6%)8 (9%)0.794 (4.5%)21 (23.6%)15 (16.9%)0.034
 Moderate10 (11.2%)15 (16.9%)5 (5.6%)13 (14.6%)11 (12.4%)6 (6.7%)
 Overweight8 (9%)3 (3.4%)2 (2.2%)2 (2.2%)8 (9%)3 (3.4%)
 Obese 2 (2.2%)4 (4.5%)0 (0%)2 (2.2%)0 (0%)4 (4.5%)
Corticosteroid
 Budesonide 2 (2.2%)4 (4.5%)4 (4.5%)0.893 (3.4%)5 (5.6%)2 (2.2%)0.69
 Inhaled corticosteroid 17 (19.1%)30 (33.7%)40 (44.9%)0.4520 (22.5%)40 (44.9%)27 (30.3%)0.42